Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
JCO Clinical Cancer Informatics
|
November 21, 2025
Multimodal Artificial Intelligence Model From Baseline Histopathology Adds Prognostic Information for Distant Recurrence Assessment in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer
Daniel Kates-Harbeck, Hans Kreipe, Oleg Gluz, et al.
JCO Precision Oncology
|
October 24, 2024
Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology
Jonathan David Tward, Huei-Chung Huang, Andre Esteva, et al.
Prostate Cancer and Prostatic Diseases
|
November 14, 2019
Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy
Joseph Marascio, Daniel E Spratt, Jingbin Zhang, et al.
Practical Radiation Oncology
|
November 26, 2019
Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial
John L Gore, Marguerite du Plessis, Jingbin Zhang, et al.
Nature
|
June 17, 2021
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
Thomas Powles, Zoe June Assaf, Nicole Davarpanah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 31, 2017
Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease
Daniel E Spratt, Kasra Yousefi, Samineh Deheshi, et al.
JCO Clinical Cancer Informatics
|
May 9, 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials
Mack Roach, Jingbin Zhang, Osama Mohamad, et al.
Prostate Cancer and Prostatic Diseases
|
April 2, 2020
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier
Jeffrey J Tosoian, Samuel R Birer, R Jeffrey Karnes, et al.
NEJM Evidence
|
February 6, 2024
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer
Daniel E Spratt, Siyi Tang, Yilun Sun, et al.
Research Square
|
May 3, 2023
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer
Daniel E Spratt, Siyi Tang, Yilun Sun, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
JCO Clinical Cancer Informatics
|
November 21, 2025
Multimodal Artificial Intelligence Model From Baseline Histopathology Adds Prognostic Information for Distant Recurrence Assessment in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer
Daniel Kates-Harbeck, Hans Kreipe, Oleg Gluz, et al.
JCO Precision Oncology
|
October 24, 2024
Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology
Jonathan David Tward, Huei-Chung Huang, Andre Esteva, et al.
Prostate Cancer and Prostatic Diseases
|
November 14, 2019
Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy
Joseph Marascio, Daniel E Spratt, Jingbin Zhang, et al.
Practical Radiation Oncology
|
November 26, 2019
Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial
John L Gore, Marguerite du Plessis, Jingbin Zhang, et al.
Nature
|
June 17, 2021
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
Thomas Powles, Zoe June Assaf, Nicole Davarpanah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 31, 2017
Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease
Daniel E Spratt, Kasra Yousefi, Samineh Deheshi, et al.
JCO Clinical Cancer Informatics
|
May 9, 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials
Mack Roach, Jingbin Zhang, Osama Mohamad, et al.
Prostate Cancer and Prostatic Diseases
|
April 2, 2020
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier
Jeffrey J Tosoian, Samuel R Birer, R Jeffrey Karnes, et al.
NEJM Evidence
|
February 6, 2024
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer
Daniel E Spratt, Siyi Tang, Yilun Sun, et al.
Research Square
|
May 3, 2023
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer
Daniel E Spratt, Siyi Tang, Yilun Sun, et al.
Page
of 7